Please provide your email address to receive an email when new articles are posted on . Postmenopausal women with vulvovaginal atrophy treated with prasterone had lower UTI prevalence. Women who used ...

In one sense, this was a miracle. I was alive. But in another, it was a nightmare. Just one week into the hormone treatment, I was a mood-swinging, hot flashing, insomniac. Perhaps the worst ...

Newly released patient satisfaction survey results from a study of a novel investigational vaginal estrogen treatment show promise for improving quality of life and satisfaction for postmenopausal ...

A phase 1/2 clinical trial found that a vaginal tamoxifen capsule was safe in postmenopausal women with vulvovaginal atrophy, researchers reported. The hormone-free capsule, DARE-VVA1 (Daré Bioscience ...

After menopause, women with multiple sclerosis experienced accelerated volume loss in global gray matter, the left hippocampus, and the left anterior cingulate, highlighting the menopausal transition ...

A large international study involving nearly 700 participants reveals that women with a precursor condition to Parkinson's disease show significantly less brain atrophy—decreased cortical thickness in ...

CALIFORNIA — There are things in life that we take for granted like riding a bike or exercising. For those living with genetic diseases though, day-to-day activities can be a challenge. "When I was ...